[Trichomegaly due to cetuximab].
Bagazgoitia
Lorea
L
Departamento de Dermatología, Hospital Ramón y Cajal, Universidad de Alcalá de Henares, Madrid, España. lorea_b@yahoo.com
Aboín
Sonsoles
S
Beà
Sònia
S
Muñoz
Ernesto
E
D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000068818:Cetuximab; D005138:Eyebrows / Q000187:drug effects; D005140:Eyelashes / Q000187:drug effects; D006201:Hair Diseases / Q000139:chemically induced*; D006801:Humans; D008297:Male
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068818:Cetuximab